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Abstract
Background: The importance of the postprandial state for the early stages of atherogenesis is
increasingly acknowledged. We conducted assessment of association between postprandial
triglycerides, insulin and glucose after ingestion of a standardized lipid-rich test meal, and soluble
cellular adhesion molecules (sCAM) in young healthy subjects.
Methods: Metabolic parameters and sICAM-1, sVCAM-1 and E-selectin were measured before
and hourly until 6 hours after ingestion of a lipid-rich meal in 30 healthy young men with fasting
triglycerides <150 mg/dl and normal fasting glucose levels. Subjects were classified as either normal
responders (NR) (postprandial triglyceride maxima < 260 mg/dl) or high responders (HR)
(postprandial triglyceride maxima > 260 mg/dl). Levels of CAM were compared in HR and NR, and
correlation with postprandial triglyceride, insulin and glucose response was assessed.
Results: Fasting sICAM-1 and sVCAM-1 levels were significantly higher in HR as compared to NR
(p = 0.046, p = 0.03). For sE-selectin there was such a trend (p = 0.05). There was a strong positive
and independent correlation between sICAM-1 and postprandial insulin maxima (r = 0.70, p <
0.001). sVCAM-1 showed significant correlation with postprandial triglycerides (AUC) (r = 0.37, p
= 0.047). We found no correlation between sCAMs and fasting insulin or triglyceride
concentrations.
Conclusion: This independent association of postprandial triglycerides with sICAM-1 may indicate
a particular impact of postprandial lipid metabolism on endothelial reaction.
Background
Coronary artery disease is the main cause of death in mid-
dle-aged men [1] and atherosclerosis is responsible for
50% of all mortality in the USA, Europe and Japan [2].
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atherosclerosis but the ‚response-to-injury‘-hypothesis of
R. Ross [2,3] is widely accepted. Several different sources
of injury to the endothelium lead to endothelial cell dys-
function. The initial stages of atherosclerosis are character-
ized by adhesion of circulating leukocytes to the
endothelial cells and subsequent transendothelial migra-
tion. This process is mediated in part by cellular adhesion
molecules (CAMs) like vascular cell adhesion molecule-1
(VCAM-1), intercellular adhesion molecule-1 (ICAM-1),
and E-selectin, expressed on the endothelial membrane,
in response to several inflammatory cytokines, including
interleukin-1, tumor necrosis factor and interferon [4].
Cellular adhesion molecules are later on detached from
the membrane and are found in the circulation in their
soluble form. CAM expression is increased in atheroscle-
rotic plaques [5,6]. Soluble forms of these adhesion mol-
ecules (sVCAM-1, sICAM-1, sE-selectin) can be detected in
the serum and are increased in conditions with an inflam-
matory component [7,8] and in atherosclerosis resulting
in coronary artery disease [9-11], carotid sclerosis [10]
and peripheral vascular disease [12]. Furthermore
increased levels of sCAMs are associated with components
of the metabolic syndrome like diabetes mellitus [13],
hypertension [14] and dislipidemia [15,16]. A slight but
significant independent correlation of sCAMs and fasting
triglycerides has been observed [15,17]. The impact of
postprandial metabolism on sCAMs has been shown dur-
ing an oral glucose tolerance test, when postprandial insu-
lin levels correlated directly with sICAM-1 [18]. Another
study compared 2 h and 4 h postprandial levels of sICAM-
1 and sVCAM-1 after a high-fat versus a high-carbohydrate
diet in diabetic and normal subjects [19]. In this study, an
increase of ICAM-1 and VCAM-1 occurred after high-fat
meal in non-diabetic subjects and was prevented by addi-
tion of vitamine E and C. Two other studies showed that
soluble adhesion molecules were increased after a high fat
meal [20,21]. There are no previous reports on the rela-
tion between postprandial triglycerides, glucose, insulin
and soluble adhesion molecules after a standardized lipid
load in healthy subjects.
The aim of the study was to evaluate soluble adhesion
molecules sICAM-1, sVCAM-1 and sE-selectin after a
mixed meal in young healthy subjects with normal or
high triglyceride response to the meal.
Results
The characteristics of the study population are shown in
Table 1. High responders showed significantly higher fast-
ing triglycerides and insulin concentrations (p < 0.01, p =
0.039, rsp.), as well as higher fasting sICAM-1, sVCAM-1
and sELAM-1 (p = 0.046, p = 0.034, p = 0.05, rsp.) concen-
trations.
Glucose
None of the subjects showed impaired glucose tolerance.
Fasting and postprandial (AUC) glucose levels were not
different between groups. In NR, the glucose concentra-
tion falls below fasting 60 min after the oMTT, in HR an
increase of glucose after 60 min resulted in a significant
difference at this time point (p = 0.01) (Figure 1).
Insulin
Fasting insulin levels were significantly different in nor-
mal and high responders (p = 0.04) with higher concen-
trations for normal responders. After ingestion of the test
meal, there was a tendency towards higher insulin levels
in HR (p = 0.10 for AUC) (Figure 2).
Triglycerides
Fasting and following the ingestion of the oral metabolic
tolerance test, mean plasma triglyceride levels were signif-
icantly higher in high responders as compared to normal
responders at any time point (p < 0.001) (Figure 3).
Soluble adhesion molecules
Soluble adhesion molecules (sICAM-1, sVCAM-1, sE-
selectin) did not increase in the postprandial state (Figure
Table 1: Characteristics of the study population
Normal Responder (n = 15) High Responder (n = 15) P-value
Age (years) 24.27 ± 2.84 25.73 ± 2.79 0.23
BMI (kg/m2) 22.43 ± 1.82 24.15 ± 2.86 0.12
WHR 0.81 ± 0.05 0.85 ± 0.06 0.08
Fasting triglycerides (mg/dl) 79.4 26.1 129.1 ± 31.3 <0.001
Fasting glucose (mg/dl) 94.1 ± 16.5 88.3 ± 9.9 0.26
Fasting insulin (mU/l) 15.3 ± 6.5 10.9 ± 4.4 0.039
Fasting sICAM-1 (ng/ml) 217.2 ± 40.8 307.3 ± 79.3 0.046
Fasting sVCAM-1 (ng/ml) 320.6 ± 177.4 418.7 ± 121.0 0.034
Fasting sELAM-1 (ng/ml) 13.2 ± 7.4 18.4 ± 9.6 0.050
Anthropometric variables, fasting metabolic parameters, and soluble adhesion molecules in 15 normal and 15 high triglyceride responders (mean ± 
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Postprandial concentrations of glucoseFigure 1
Postprandial concentrations of glucose. Plasma glucose 
concentrations following ingestion of an oral metabolic toler-
ance test in 15 normal (●, NR) and 15 high (, HR) triglyc-
eride responders (mean ± SEM).
Postprandial concentrations of insulinFigure 2
Postprandial concentrations of insulin. Plasma insulin 
concentrations following ingestion of an oral metabolic toler-
ance test in 15 normal (●, NR) and 15 high (, HR) triglyc-
eride responders (mean ± SEM).
Postprandial concentrations of triglyceridesFigure 3
Postprandial concentrations of triglycerides. Plasma 
triglyceride concentrations following ingestion of an oral 
metabolic tolerance test in 15 normal (●, NR) and 15 high 
(, HR) triglyceride responders (mean ± SEM).
Postprandial concentrations of sICAM-1Figure 4
Postprandial concentrations of sICAM-1. Plasma 
sICAM-1 concentrations following ingestion of an oral meta-
bolic tolerance test in 15 normal (●, NR) and 15 high (, 
HR) triglyceride responders (mean ± SEM).
Lipids in Health and Disease 2008, 7:32 http://www.lipidworld.com/content/7/1/324, 5, 6). Neither the levels at single postprandial time
points nor the means over observation time differed from
fasting concentrations for sICAM-1, sVCAM-1 and sE-
selectin. Therefore, the fasting values were used to analyze
differences between NR and HR. sICAM-1 levels were sig-
nificantly different between NR (210.2 ± 5.94 ng/ml) and
HR (304.3 ± 5.69 ng/ml, p = 0.046). Plasma levels of
sVCAM-1 were also significantly higher in HR (p = 0.047).
Soluble E-selectin levels were not significantly different
but tended to be higher in HR (18.4 ± 9.6 vs. 13.2 ± 7.4, p
= 0.05).
Relationship of sCAM and metabolic parameters
In univariate linear regression analysis, fasting soluble
ICAM-1 correlated with with postprandial insulin AUC
and the maximum of insulin after oMTT (r = 0.39, p <
0.04, r = 0.7, p < 0.001 rsp.). There was no significant cor-
relation with fasting insulin concentration. Correlation
between fasting sVCAM-1 and postprandial triglycerides
again showed a stronger correlation (r = 0.37) than with
fasting triglycerides (r = 0.34, p = 0.047). There was no sig-
nificant correlation between fasting sE-selectin and fasting
or postprandial glucose, insulin or triglycerides (Table 2).
In multivariate linear regression analysis, including fast-
ing, maximal and AUC-values of insulin, glucose, and
triglycerides, we found a strong prediction of fasting
sICAM-1 through triglycerides (AUC), insulin maxima,
and postprandial glucose (AUC) (r2 0.67, p < 0.001). 67%
of the variance of fasting sICAM-1 concentration was pre-
dicted by these three parameters, although the latter con-
tributed to the model goodness but was not significant as
an independent predictor for fasting sICAM-1. For fasting
sE-selectin and sVCAM-1, the metabolic parameters were
much weaker predictors. Only 8% at most of the variance
of fasting sE-selectin and sVCAM-1 where predicted when
metabolic parameters were included. sE-selectin was pre-
dicted significantly through postprandial triglycerides
which remained in the model with a borderline signifi-
cance for maximal triglycerides (p = 0.08), while for
Postprandial concentrations of sVCAM-1Figure 5
Postprandial concentrations of sVCAM-1. Plasma 
sVCAM-1 concentrations following ingestion of an oral meta-
bolic tolerance test in 15 normal (●, NR) and 15 high (, 
HR) triglyceride responders (mean ± SEM).
Postprandial concentrations of E-SelectinFigure 6
Postprandial concentrations of E-Selectin. Plasma E-
Selectin concentrations following ingestion of an oral meta-
bolic tolerance test in 15 normal (●, NR) and 15 high (, 
HR) triglyceride responders (mean ± SEM).
Table 2: Correlation coefficients of soluble adhesion molecules 
with fasting and postprandial metabolic parameters
sICAM-1 sVCAM-1 sELAM-1
Fasting glucose -0.070 0.042 -0.088
Glucose max 0.073 0.147 0.241
Glucose AUC 0.089 0.189 0.057
Fasting insulin -0.038 0.047 -0.185
Insulin max 0.699* 0.013 0.071
Insulin AUC 0.385* 0.249 -0.004
Fasting triglycerides 0.212 0.337 0.087
Triglycerides max 0.290 0.316 0.310
Triglycerides AUC 0.288 0.366* 0.164
Correlation coefficients of fasting and postprandial glucose, insulin, 
and triglycerides assessed by univariate linear regression analysis 
following ingestion of an oral metabolic tolerance test in 30 healthy 
men. The numeric values are standardized regression coefficients. 
*significant correlation in univariate analysisPage 4 of 7
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an significant predictor.
Discussion
In this study we showed, that healthy young men with
normal fasting triglycerides but high postprandial triglyc-
erides (HR) showed higher levels of sCAMs after a lipid-
rich meal compared to subjects with lower postprandial
triglycerides (NR). Furthermore, HR are characterized by
higher postprandial glucose concentrations, as important
early characteristics of the metabolic syndrome, whereas
fasting glucose was low in these subjects. The NR showed
an initial decrease of glucose concentrations after oMTT
which is a sign of intact glucose-insulin regulation and
was significantly different from the 60 min increase of glu-
cose in HR.
Ferri et al. [18] found an increase of sICAM-1 after an oral
glucose tolerance test and a correlation with postprandial
insulin in subjects with impaired glucose tolerance and
hyperlipidemia. Furthermore subjects with isolated
hyperlipidemia had normal levels of sICAM in their study.
The authors concluded that glucose metabolism and insu-
lin resistance, not hyperlipidemia, has direct impact on
levels of sCAM. We showed that in fact postprandial insu-
lin correlates with sICAM. The strongest correlation was
seen between both insulin maxima and the insulin area-
under-the-curve and sCAMs, especially for sICAM-1. But
as there was no postprandial augmentation of sCAM in
our study, the conclusion of Ferri et al. that insulin has
direct impact on CAMs is not supported by our results.
Instead we conclude that there is a general metabolic
abnormality seen in high responders which may be an
abnormality which eventually may lead to the inflamma-
tory abnormalities accompanying the metabolic syn-
drome.
High responders showed higher postprandial lipid perox-
idation and reduced intracellular levels of antioxidant
vitamin C in previous studies [22]. The association
between high postprandial triglyceride and insulin levels
after a mixed meal with high CAMs is presumably indicat-
ing an early stage of endothelial dysfunction.
In this study strong correlations between postprandial
insulin levels and sICAM were seen whereas the correla-
tion between fasting insulin levels and sICAM was less
pronounced. Moreover, the linear relationship between
sICAM, postprandial triglycerides, and insulin maxima
was independent of fasting metabolic parameters in mul-
tiple regression analysis. Again, postprandial triglyceride
levels showed a significant correlation to sVCAM, while
this correlation was not found with fasting triglycerides.
In contrast, Ridker et al. [9] found a slight but significant
correlation between sICAM-1 and fasting triglycerides in
patients with risk for future myocardial infarction. In this
study, the postprandial metabolism was not examined.
The important role of the postprandial state for induction
of early stages of metabolic syndrome and atherosclerosis
is evident because of stronger and independent postpran-
dial correlations.
Intervention studies showed that metabolic disorder as
well as diet influence CAM levels and, thus, the endothe-
lial activation. In poorly controlled NIDDM diabetics,
increased sE-selectin levels returned to normal after short-
term improvement of glycemic control [23]. In other stud-
ies, lipid lowering therapy decreased levels of sE-selectin
in hypercholesteremic patients [15] and n3-fatty acid
treatment decreased sE-selectin and sICAM-1 [17] in
hypertriglyceridemic patients.
According to sICAM-1, we also found higher levels of fast-
ing sVCAM-1 in high responders compared to normal
responders. sE-selectin concentrations were also higher in
HR, although the difference was statistically not signifi-
cant. In unstimulated endothelium, adhesion molecule
expression is low, with the exception of ICAM-1, which is
constitutively expressed to a higher degree. Because of the
"premetabolic" syndrome in high responders, we assume
that ICAM-1 is expressed constantly on endothelial cells
in these persons in a higher degree than E-selectin and
VCAM, which can explain the most pronounced differ-
ence in HR and NR for sICAM-1.
Correlation analysis of any CAMs with postprandial glu-
cose in our collective was negative, implicating the impor-
tance of insulin and triglycerides in early stages of
metabolic syndrome when glucose levels are still normal.
In our subjects there was no evidence of clinical mani-
fested atherosclerosis disease, although early stages of
atherosclerosis can not be excluded. HR had a tendency
for both higher sCAM levels and elevated postprandial
triglyceride and insulin levels. We showed for the first
time a correlation between postprandial triglycerides,
insulin and sCAMs in healthy subjects. Thus, it may be
suggested that postprandial triglycerides and/or insulin
and sCAMs are reasonable markers for early metabolic
abnormalities and endothelial activation leading to the
metabolic syndrome and atherosclerosis, however further
studies are needed to confirm this. A limitation of this
study is the limited sample size which could explain the
tendency for elevated sE-selectin in HR, but without
reaching statistical significance. Further studies with alter-
ations of oxidative agens in oral lipid loads are needed to
examine postprandial levels of adhesion molecules.
In this study soluble adhesion molecules did not increase
within the 6 h observation period after an oral lipid load.Page 5 of 7
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as 2 hours after a glucose load [19]. An increase of soluble
adhesion molecules after high fat meals was shown in
other studies [20,21]. Incubation of HUVEC endothelial
cells with chylomicrons can induce E-selectin and VCAM-
1 expression [24,25].
We assume that the retinol content of our test meal atten-
uated the postprandial rise of soluble adhesion mole-
cules. We did indeed observe that consumption of the
lipid load without retinol increases postprandial levels of
sICAM and sE-selectin, and that this effect is prevented by
retinol (Pfeuffer et al., personal communication). This fits
with the results of Nappo et al. [19]. When these authors
administered a high-fat diet meal with or without supple-
mentation of vitamin E and C as antioxidative agents to
diabetic and healthy subjects, the high-fat meal without
antioxidants significantly increased postpranadial levels
of sICAM-1 and sVCAM-1. This effect was prevented by
addition of vitamin E and C in both groups.
Conclusion
In conclusion, soluble adhesion molecules are strongly
associated with postprandial but not fasting triglycerides
and insulin in young, healthy men which could have
implications for future atherogenic risk assessment in




Thirty healthy male subjects with normal fasting triglycer-
ides (<150 mg/dl) were recruited according to their post-
prandial response to a standardized lipid-rich meal. In a
previous study, a bimodal distribution of triglyceride
maxima following an oral lipid load was observed. In
total 15% of the subjects did respond with postprandial
triglyceride maxima above 260 mg/dl. The cut-off point to
identify the high responders (HR) was chosen according
to a bimodal distribution of triglyceride maxima [26,27].
Fifteen normal responders (NR) and fifteen HR were
selected out of 182 subjects who underwent the standard-
ized lipid-rich meal in the current study. Inclusion criteria
were normal BMI (<25 kg/m2) and fasting blood glucose
levels < 110 mg/dl. Subjects had no history of present or
past hypertension, hyperlipidemia, diabetes, or cardiovas-
cular disease. All subjects were following previously ad
libidum diets, had no recent change in body weight or
intercurrent illness and were taking no medication. The
study complies with the Declaration of Helsinki. The pro-
tocol of the study was approved by the ethics commitee of
the University of Kiel, the subjects gave informed written
consent before being tested. The characteristics of the
study population are reported in table 1.
Standardized lipid-rich meal
Studies began at 8 AM after a 12-h-overnight fast. After
fasting blood was drawn, the subjects consumed 500 ml
of a standardized mixed liquid meal (oral metabolic tol-
erance test, oMTT) containining the following ingredi-
ents: 30 g of protein (11,9 energy%), 75 g of
carbohydrates (29,6 energy%)(93% saccharose, 7% lac-
tose), 58 g of fat (51,6 energy%)(65% saturated, 35%
unsaturated fatty acids), 10 g of alcohol (6,9 energy%),
600 mg cholesterol and 30.000 IU retinylpalmitate
(Nutrichem, Roth, Germany). The total energy content
was 1017 kcal (4255 kJ). The test meal was drunk within
15 minutes. Blood withdrawal was repeated at 1, 2, 3, 4, 5
and 6 h after ingestion of oMTT. Subjects were allowed to
walk or sit, as they wished, but not to exercise during the
test. Ad libitum drinking of water or fruit tea without
sugar was permitted. Blood was collected through a
venous in-dwelling catheter placed in a cubital vein. For
assessing glucose tubes containing 1 mg/ml fluoride and
1.2 mg/ml EDTA, for determing triglycerides, insulin and
cellular adhesion molecules tubes containing 1.6 mg/ml
Potassium EDTA were used. Plasma was separated by cen-
trifugation at 6.48 e+7/min, 4°C and stored at -20°C until
analysis.
Laboratory analyses
Fasting and postprandial triglyceride and glucose were
determined automatically and in duplicate with the kone
lab 20i analyzer (Kone, Espoo, Finland) using enzymatic
test kits (glucose: Roche, Mannheim, Germany; triglycer-
ides: Boehringer, Mannheim, Germany). Insulin was
measured with a radioimmunassay (Biochem Immuno-
systems, Freiburg, Germany). Plasma concentrations of
sICAM-1, sVCAM-1 and sE-selectin were measured in
duplicate using a quantitative sandwich ELISA (Boe-
hringer, Mannheim, Germany). The inter-assay and intra-
assay coefficients of variation were < 10%.
Statistical analyses
The Kolmogorov-Smirnov test was used to determine
whether each considered variable had a normal distribu-
tion. Comparisons of baseline data among the groups
were performed using the unpaired Student's t test for nor-
mally distributed parameters and with the Mann-Whit-
ney-U test for parameters not following a normal
distribution. The paired Student's t test was used for com-
parison of CAMs before and after ingestion of the test
meal. If differences reached statistical significance, post-
hoc analysis with a two-sided paired t test was used to
assess differences at individual time periods in the study,
using Bonferroni correction to adjust for for multiple
comparisons. The statistical significance of postprandial
change of sCAMs was determined by comparing the sum-
marized postprandial values (area under the curve, AUC)
with the fasting values by a t test or a Mann-Whitney-UPage 6 of 7
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Spearman's coefficient was used to describe correlations
of pooled data from NR and HR. In further exploratory
analyses, multiple linear regression analysis was used to
examine the relative contributions and overlap of meta-
bolic factors possibly contributing to sCAM levels. Results
were given as mean ± SEM. The 0–9 h AUC was calculated
by the trapezoidal method [28]. Statistical significance
was defined as p < 0.05.
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